Physician
Wikoff, Catherine
Wikoff, Catherine was paid $258K by Medicaid between Oct 2019 and Oct 2024, across 22 billing codes. Its largest line is 59409, Vaginal delivery only (with or without episiotomy and/or forceps) — 17% of everything it billed.
33Billing provider infoWIKOFF, CATHERINE
ROGERS, AR 72758
ROGERS, AR 72758
33aNPI1770576613assigned 08/25/2005
33bProvider typeObstetrics & Gynecology Physician
28Total paid$258K
24GClaims5,034
24DCodes billed22
24AFirst – last monthOct 2019 – Oct 2024
Compared with peers
Next to other Obstetrics & Gynecology Physician providers in Arkansas
Rank by total paid#6 of 59
Median peer was paid$8K
This provider vs. median32×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 80 | $3K | |
| 2020 | 1,560 | $64K | |
| 2021 | 1,886 | $93K | |
| 2022 | 786 | $59K | |
| 2023 | 321 | $13K | |
| 2024incomplete | 401 | $25K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | 17% | 48 | 27 | $44K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 14% | 861 | 673 | $37K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 14% | 858 | 667 | $37K |
| 0502F | 12% | 687 | 499 | $31K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.5% | 319 | 224 | $22K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 7.8% | 705 | 557 | $20K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.9% | 282 | 186 | $18K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 3.7% | 169 | 141 | $10K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 3.7% | 230 | 127 | $9K |
| 87481 | 2.6% | 93 | 69 | $7K | |
| 87511 | 1.6% | 91 | 70 | $4K | |
| 76830 | Ultrasound, transvaginal | 1.4% | 85 | 64 | $4K |
10 more codes
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1.4% | 77 | $4K |
| 76801 | 1.3% | 71 | $3K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 101 | $3K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 48 | $2K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 37 | $2K |
| 59025 | Fetal non-stress test | <1% | 125 | $1K |
| 87653 | <1% | 14 | $659.94 | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 12 | $579.00 |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 19 | $534.53 |
| 81025 | <1% | 102 | $347.20 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.